Harith Rajagopalan was named Chief Executive Officer of Fractyl Health, Inc. As of October 28, 2026, Fractyl Health, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on October 22, 2026, naming 1 appointment (Form 8-K, October 22, 2026).
Sell to companies like Fractyl Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Fractyl Health, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-10-22. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Fractyl Health, Inc. files it.
Layoffs on record: 1 filing or notice, latest 2026-10-22 (layoff filings and notices).
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-22 | In | Chief Executive Officer | 8-K, 2026-10-22 |
Selling to them or working with them? See who runs Fractyl Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Fractyl Health, Inc. and the records around it.
Fractyl Health, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Who owns it
Companies that share a holder
- Mithril LP also filed stake reports on 1 other company: BlackSky Technology, Inc. (Aug 2026)
- Maverick Capital, Ltd. also filed stake reports on 5 other companies: Infleqtion, Inc. (May 2026), Invivyd, Inc. (Feb 2026), Peabody Energy Corporation (Feb 2026)
- SilverArc Capital Management, LLC also filed stake reports on 8 other companies: Cellectar Biosciences Inc (Aug 2026), ELUTIA INC. (Aug 2026), TELA BIO, INC. (Aug 2026)
Watch Fractyl Health, Inc.
Get an email when Fractyl Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Fractyl Health, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Fractyl Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Fractyl Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Who leads Fractyl Health, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Executive Officer: Harith Rajagopalan, appointed (filed 2026-10-22).
New leaders reset buying decisions — get the Full Report on Fractyl Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Executive Officer at Fractyl Health, Inc., with the record behind each one.
Find candidates like Chief Executive Officer at Fractyl Health, Inc.Every change, in the filing's words
Appointed: Harith Rajagopalan, Chief Executive Officer
Appointment Of President In connection with Mr. Caplan's departure, on October 21, 2026, the Board of Directors of the Company appointed Harith Rajagopalan, M.D., Ph.D., the Company's Co-Founder, Chief Executive Officer and a member of the Board, to serve as President of the Company, effective as of the Separation Date, in addition to his continuing roles as Chief Executive Officer and as a director of the Company.
Tools for this story
Each opens in a new tab, filled in for Fractyl Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.